Figure 3 — Bezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling

Research Paper|Volume 16, Issue 19|pp. 12769–12780

Bezafibrate mitigates cardiac injury against coronary microembolization by preventing activation of p38 MAPK/NF-κB signaling

Back to articleFigure 3(3 of 7)

100%

Figure 3.Bezafibrate ameliorated oxidative stress in cardiac tissues of CME rats. (A) GPx levels; (B) SOD activity; (C) TBARS level; (D) NOX activity (n=12, ^**, p<0.01 vs. control group; ^#, ^##, p<0.05, 0.01 vs. CME group).